Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Clinical trial NCT06122077 · RECRUITING

Trial details

NCT number: NCT06122077
Sponsor: Freenome Holdings Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer Diagnosis

Start date: 2023-11-28
Primary completion: 2026-06-15
Enrollment: 20000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.